ADRA1A and drug-induced dyskinesia: Examples include hERG (KCNH2) for QT prolongation, α1A adrenergic receptor (ADRA1A) modulation for arrhythmia (agonists) or orthostatic hypotension (antagonists), and dopamine D1 (DRD1) antagonism for dyskinesia and tremors7.